site stats

Clls stock price

WebCLLS Stock Price Today. Cellectis S.A. (CLLS) stock declined over-17.70% intraday to trade at $2.51 a share on NASDAQ.The stock opened with a loss of-25.90% at $2.26 and touched an intraday high of $2.54, falling-17.70% against the last close of $3.05.The Cellectis S.A. in stock market went to a low of $2.25 during the session. WebApr 11, 2024 · The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $8.57. A number of research firms recently commented on CLLS.

Cellectis (CLLS) Stock Price Today, News, Quotes, FAQs …

WebFind the latest Cellectis S.A. (CLLS) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Cellectis S.A. (CLLS) stock discussion in Yahoo Finance's forum. … Discover historical prices for CLLS stock on Yahoo Finance. View daily, weekly or … View the basic CLLS option chain and compare options of Cellectis S.A. on … Get the detailed quarterly/annual income statement for Cellectis S.A. (CLLS). Find … NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend … See Cellectis S.A. (CLLS) stock analyst estimates, including earnings and … Find out all the key statistics for Cellectis S.A. (CLLS), including valuation … Stocks sink after Fed minutes despite cooler inflation: Stock market news … Find the latest Cellectis S.A. (CLLS) stock quote, history, news and other vital … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … WebGet Cellectis SA (CLLS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. grunthal grocery store https://adoptiondiscussions.com

Cellectis S.A. (CLLS) Stock Forecast & Price Prediction 2025, 2030 ...

WebFind the latest Calyxt, Inc. (CLXT) stock quote, history, news and other vital information to help you with your stock trading and investing. WebCrispr Therapeutics stock opened the day at $45.00 after a previous close of $45.40. The latest price was $45.09 (25-minute delay). Crispr Therapeutics is listed on the NASDAQ, has a trailing 12-month revenue of around USD1.2 million and employs 458 staff. Market capitalization: $3,523,372,288 PEG ratio: 0 Web33 Likes, 1 Comments - JASTIP IKEA INFORMA ACE, DLL (@mellya_gallery) on Instagram: "READY STOCK SIAP KIRIM LELET BHAYYYY ⁣⁣ ⁣⁣ Selimut Lembut, Bulu Halus Te..." grunthal hockey

CLLS Stock Price Cellectis S.A. ADR Stock Quote (U.S.: Nasdaq ...

Category:Cellectis S.A. (NASDAQ:CLLS) Receives Average Recommendation …

Tags:Clls stock price

Clls stock price

CLLS - Cellectis S.A. ADR Stock Price - Barchart.com

WebMar 23, 2024 · CLLS A complete CLLS overview by MarketWatch. View the latest market news and prices, and trading information. WebMar 31, 2024 · View Cellectis SA CLLS investment & stock information. Get the latest Cellectis SA CLLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and …

Clls stock price

Did you know?

WebApr 6, 2024 · According to 10 analysts, the average rating for CLLS stock is "Buy." The 12-month stock price forecast is $23.95, which is an increase of 1,163.85% from the latest … WebApr 10, 2024 · CLLS: Cellectis options chain stock quote. Get the latest options chain stock quote information from Zacks Investment Research.

WebWall Street Stock Market & Finance report, prediction for the future: You'll find the Clover Health Investments Corp - Class A share forecasts, stock quote and buy / sell signals below. According to present data Clover Health Investments Corp - Class A's CLOV shares and potentially its market environment have been in bearish cycle last 12 ... WebMar 29, 2024 · Cellectis S.A. (NASDAQ: CLLS)’s stock price has decreased by -4.67 compared to its previous closing price of 2.04. Nevertheless, the company has seen a -1.02% plunge in its stock price over the last five trading sessions. In today's chaotic marketplace, the biggest gains will come from some ...

WebCLLS Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $7.67 with a … WebNASDAQ:CLLS: NASDAQ: Common Stock Price Change % Change Share Price Bid Price Offer Price : 0.00: 0.0%: 1.97: 1.81: 1.99: High Price Low Price Open Price Shares Traded Last Trade; 1.99: 1.89: 1.99: 44,698: 22:16:11: Cellectis (CLLS) News Headlines. Real-Time news about Cellectis SA (NASDAQ): 0 recent articles ...

WebAverage analysts price target $37 Buy rating Cellectis SA is a biopharmaceutical company, which engages in the research and development of genome engineering technology. The company operates through the followingEntry level $16 = Target price $19.50 = Stop loss $15 Significant break above 200ma. Average analysts price target $37 Buy rating ...

WebView the latest Cellectis S.A. ADR (CLLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. grunthal insuranceWebApr 12, 2024 · 7 brokers have issued twelve-month price targets for Atara Biotherapeutics' stock. Their ATRA share price forecasts range from $3.00 to $50.00. On average, they expect the company's share price to reach $19.25 in the next year. This suggests a possible upside of 594.9% from the stock's current price. View analysts price targets for ATRA … grunthal homes for saleWebCellectis SA (CLLS) Stock Price & Analysis. Follow. 766 Followers. Portfolio. CLLS Stock Chart & Stats. Advanced Chart > 1d 5d 3m 6m YTD 1y 3y 5y. Day’s Range $0 - $0. 52-Week Range $1.77 - $4.43. ... Cellectis SA lowest stock price was $1.77 and its highest was $4.43 in the past 12 months. What is Cellectis SA’s market cap? Currently, no ... final cut pro ken burns effectWebJun 2, 2024 · NASDAQ:CLLS: NASDAQ: Common Stock Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade : 0.00: 0.0%: 2.12: 1.70: final cut pro in windowsWebCellectis S.A. ADR analyst ratings, historical stock prices, earnings estimates & actuals. CLLS updated stock price target summary. ... Stock Price Target CLLS. High $ 16.00: Median $ 7.00: Low ... final cut pro missing fileWebApr 11, 2024 · The average 1 year target price among brokerages that have covered the stock in the last year is $8.57. A number of equities research analysts have issued reports on CLLS shares. grunthal light showWebApr 11, 2024 · Cellectis stock opened at $1.96 on Tuesday. The company's 50-day moving average price is $2.18 and its 200-day moving average price is $2.37. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.16. The company has a market cap of $108.94 million, a PE ratio of -0.84 and a beta of 2.12. grunthal lumber grand opening